Literature DB >> 10549407

Paeoniflorin reverses guanethidine-induced hypotension via activation of central adenosine A1 receptors in Wistar rats.

J T Cheng1, C J Wang, F L Hsu.   

Abstract

1. Intravenous injection of paeoniflorin, a glycoside purified from the root of Paeonia lactiflora, reversed guanethidine-induced hypotension in Wistar rats. 2. Pretreatment with the adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine inhibited this effect of paeoniflorin in a dose-dependent manner. 3. The action of paeoniflorin was not modified by 8-(p-sulfophenyl)theophylline, the polar antagonist of the adenosine A1 receptor, which is not able to enter the central nervous system. 4. We conclude that paeoniflorin can reverse guanethidine-induced hypotension via activation of adenosine A1 receptors in the brain of Wistar rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549407     DOI: 10.1046/j.1440-1681.1999.03132.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

1.  Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor-mediated transactivation of epidermal growth factor receptor.

Authors:  Min Zhong; Wan-ling Song; Ye-chun Xu; Yang Ye; Lin-yin Feng
Journal:  Acta Pharmacol Sin       Date:  2015-02-09       Impact factor: 6.150

2.  Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model.

Authors:  Dou Yin; Yuan-Yuan Liu; Tian-Xiao Wang; Zhen-Zhen Hu; Wei-Min Qu; Jiang-Fan Chen; Neng-Neng Cheng; Zhi-Li Huang
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

3.  Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists.

Authors:  Da-Zhi Liu; Ke-Qiang Xie; Xin-Quan Ji; Yang Ye; Cheng-Liang Jiang; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

4.  Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.

Authors:  Hua-Qing Liu; Wei-Yu Zhang; Xue-Ting Luo; Yang Ye; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

5.  Beneficial Effects of Paeoniflorin Enriched Extract on Blood Pressure Variability and Target Organ Damage in Spontaneously Hypertensive Rats.

Authors:  Bo Li; Zheng-Biao Yang; Shan-Shan Lei; Jie Su; Min-Xia Pang; Chao Yin; Guo-Yang Chen; Chao-Wen Shan; Bo Chen; Hui-Ming Hu; Su-Hong Chen; Gui-Yuan Lv
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-24       Impact factor: 2.629

Review 6.  Plant and fungi derived analgesic natural products targeting voltage-gated sodium and calcium channels.

Authors:  Aida Calderon-Rivera; Santiago Loya-Lopez; Kimberly Gomez; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2022-12       Impact factor: 3.493

7.  Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation.

Authors:  Jian Hao; Xue Yang; Xiu-Li Ding; Lei-Ming Guo; Cui-Hong Zhu; Wei Ji; Tong Zhou; Xiong-Zhi Wu
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.